ICMR Drafts Ethical Framework for Non-Regulatory Clinical Trials
GS4GS2
The Indian Council of Medical Research (ICMR) has invited public consultation on new draft ethical guidelines for non-regulatory clinical trials to enhance transparency and participant safety in biomedical research.
The Indian Council of Medical Research (ICMR) has taken a significant step toward strengthening the ethical architecture of biomedical research in India by releasing draft guidelines for 'non-regulatory' clinical trials. While regulatory trials—those conducted for drug approval or licensing—are governed by the Central Drugs Standard Control Organization (CDSCO), non-regulatory trials often involve academic research, observational studies, or public health interventions that previously lacked a unified, comprehensive ethical framework.
This initiative is crucial for ensuring that the rights, safety, and well-being of research participants are protected, regardless of the trial's regulatory status. By inviting public consultation, the ICMR aims to foster a culture of transparency and accountability in scientific inquiry. The proposed guidelines are expected to address critical issues such as informed consent, data privacy, the management of potential conflicts of interest, and the ethical oversight of research conducted by academic institutions and NGOs.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.